Cipher Pharmaceuticals Schedules Q4 2022 Earnings Release and Conference Call

MISSISSAUGA, ON, March 10, 2023 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) ("Cipher" or "the Company") today announced that it will release its financial results for the three and twelve months ended December 31, 2022 after market close on March 16, 2023. The Company will also host a conference call on Friday, March 17, 2023 at 8:30am ET to discuss the results and corporate developments. 

CONFERENCE CALL DETAILS

DATE:	Friday, March 17, 2023
TIME:	8:30 a.m. EDT
DIAL-IN NUMBER:	[phone] or [phone]
CONFERENCE ID:	02194569
REPLAY DIAL-IN:	[phone] (playback 194569#)
	Expires March 24, 2023
WEBCAST:	https://app.webinar.net/VDZxNRGzWPq

About Cipher Pharmaceuticals Inc.

Cipher Pharmaceuticals (TSX: CPH) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products either directly in Canada or indirectly through partners in Canada, the U.S., and South America. For more information, visit www.cipherpharma.com.

SOURCE Cipher Pharmaceuticals Inc.

James Bowen, CFA. Investor Relations - Cipher Pharmaceuticals, [phone]